New hope for rare kidney cancers: testing a powerful drug duo
Disease control
Recruiting now
This study is testing whether a combination of two drugs, pembrolizumab and enfortumab vedotin, can help control two rare and aggressive types of kidney cancer. It will enroll about 23 adults with advanced collecting duct carcinoma or renal medullary carcinoma. The main goal is t…
Phase: PHASE2 • Sponsor: Giuseppe Procopio • Aim: Disease control
Last updated Mar 24, 2026 12:01 UTC